Patients on Eli Lilly’s next-generation obesity shot lost nearly 30% of their body weight on average in a trial that tracked them for a little more than a year—a result that’s far better than the most ...

Eli Lilly has surpassed analysts’ highest hopes for the efficacy of retatrutide, linking the triple agonist to 28.7% weight loss and a 75.8% reduction in pain scores in patients with obesity and knee ...

Analysts were hoping for a safety profile similar to what was achieved in Phase II but an abnormal sense of touch, called dysesthesia, has emerged in the late-stage TRIUMPH-4 trial. Eli Lilly’s triple ...

Erin Burnett speaks to Eli Lilly CEO David Ricks on major changes to weight-loss drugs and expanded manufacturing. US should leave NATO, new Republican bill says Cannabis plants found in culvert ...

A key catalyst may be right around the corner. Though Lilly stock has climbed more than 100% over the past three years, I think it still has room to run in both the short term and the long term. Let's ...

Tone your abs at home with this simple no-equipment workout. #FlatBelly #AbsWorkout #HomeFitness Judge Delivers Final Blow to Trump Case Trump ally Elise Stefanik attacks Speaker Johnson’s leadership ...

Just when you think the New York Giants can’t get any worse, they go and find a new way. As for this week’s grades, read on if you dare. Quarterback Jaxson Dart is going to have a very short NFL ...

Ed Weeks is set for one of the lead roles in the CBS comedy pilot “Eternally Yours,” Variety has learned. The single-camera show was picked up to pilot at the broadcaster in July, while CBS had ...

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox. From our morning news briefing to a weekly Good News Newsletter, get the ...

Eli Lilly just agreed to lower the price of its blockbuster GLP-1 weight loss drug. More than half of the company's revenue comes from just two weight loss drugs. Wall Street may be pricing in too ...